SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-23-000092
Filing Date
2023-08-10
Accepted
2023-08-10 07:19:17
Documents
53
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20230630.htm   iXBRL 10-Q 1105382
2 EX-31.1 exhibit311-2023630q1.htm EX-31.1 9512
3 EX-31.2 exhibit312-2023630q1.htm EX-31.2 9413
4 EX-32.1 exhibit321-2023630q1.htm EX-32.1 4459
5 EX-32.2 exhibit322-2023630q1.htm EX-32.2 4480
  Complete submission text file 0001764013-23-000092.txt   4292364

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20230630.xsd EX-101.SCH 26813
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20230630_cal.xml EX-101.CAL 37920
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20230630_def.xml EX-101.DEF 176191
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20230630_lab.xml EX-101.LAB 393101
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20230630_pre.xml EX-101.PRE 265701
47 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20230630_htm.xml XML 328053
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 231157173
SIC: 2836 Biological Products, (No Diagnostic Substances)